Skip to main content

Show 11 results Show all

Performance Monitoring for Action (PMA): Family Planning

PMA generates frequent, high-quality surveys monitoring key health indicators in nine countries in Africa and Asia. Data is available open-source for research, program planning, and policy-making. PMA family planning briefs provide a snapshot of select indicators through charts, graphs and tables. Key indicators for family planning include unmet need for family planning, modern contraceptive prevalence rate (​mCPR), and family planning access, equity, quality, and choice.

Institutional Author(s): Johns Hopkins Bloomberg School of Public Health
Publication date: 2021

Tool Web page

Must-have Family Planning Resources

This list was curated by the Knowledge SUCCESS team by asking projects funded by USAID Population and Reproductive Health to submit resources that they have developed or used.

Institutional Author(s): Knowledge SUCCESS
Publication date: December, 2020

Guide Web page

Ready to Save Lives: Sexual and Reproductive Health Care in Emergencies

The purpose of the toolkit is to bring together existing learning and guidance as a starting point for stakeholders to begin SRH preparedness work. Within the SRH sector the field of preparedness is relatively new and growing. More collective effort is required to further evaluate the impact of preparedness efforts and push the field forward. This effort is a first attempt at synthesizing draft guidance for SRH preparedness, and is intended for field testing. The toolkit recognizes the longstanding work of the field of emergency and disaster risk management, and endeavors to bridge that work with the human rights-oriented and peoplecentered field of sexual and reproductive health.

Institutional Author(s): Family Planning 2020 (FP2020)
Publication date: December, 2020

Guide Web page

Digital Health Compendium for family planning

This compendium aims to consolidate emerging information on applying digital technology in voluntary family planning programs to inform the adoption and scale-up of successful approaches, as well as encourage learning and adaptation from approaches that were less successful. The interactive website enables users to explore case studies across a range of digital health solutions to enhance voluntary family planning programs in low and middle-income countries.

Institutional Author(s): Policy Advocacy Communication Enhanced for Population and Reproductive Health (PACE)
Publication date: October, 2020

Guide Web page

Optimizing the World Health Organization COVID-19 Guidance

In the publication, “Maintaining essential health services: operational guidance for the COVID-19 context” the WHO outlines strategies governments should take to ensure populations retain access to essential health services, including sexual and reproductive health (SRH) care, during and beyond the current COVID-19 pandemic. This document, developed with the input of international nongovernmental organizations and local civil society actors to support the implementation of the WHO guidance at the country level, recommends concrete policy, programmatic and budgetary decisions to optimize and implement the WHO guidance and other relevant SRH guidelines at the national and subnational levels. As a living document, the recommendations provide a snapshot of the current context. This document is designed to be updated with new evidence and advocacy recommendations by governments, technical experts, civil society and advocates worldwide with the COVID-19 response and through recovery.

Institutional Author(s): Population Action International (PAI), Family Planning 2020 (FP2020)
Publication date: October, 2020

Maintaining essential health services: operational guidance for the COVID-19 context

This publication recommends practical actions that countries can take at national, subregional and local levels to reorganize and safely maintain access to high-quality, essential health services in the pandemic context. The guidance outlines strategies governments should take to ensure populations retain access to essential health services, including sexual and reproductive health care, during and beyond the current COVID-19 pandemic. It is intended for decision-makers and managers at the national and subnational levels.

Institutional Author(s): World Health Organization (WHO)
Publication date: June, 2020

The Highs, Lows, and Squishy Middle of Contraceptive Product Introduction

As part of the Global Health Science and Practice (GHTechX) conference, CHAI, FHI 360, PATH, the Population Council, PSI, and WCG hosted an April 22, 2021 session to synthesize lessons learned across contraceptive introduction of implants, DMPA-SC self-injection, hormonal IUS and other methods. During the session, experts from Kenya, Madagascar, Uganda, and the United States outlined essential steps for the process of contraceptive product introduction, described common challenges, and shared tools and approaches based on experiences with the three methods. Session slides are available below. To watch the recording of this and many other sessions, register for free on the GHTechX website.

Institutional Author(s): Clinton Health Access Initiative (CHAI), FHI 360, PATH, Population Council
Publication date: April, 2021

Family planning provision in pharmacies and drug shops: an urgent prescription

Drug shops and pharmacies have long been recognized as the first point of contact for health care in developing countries, including family planning (FP) services. Drug shop operators and pharmacists should not be viewed as mere merchants of short-acting contraceptive methods, as this ignores their capacity for increasing uptake of FP services and methods in a systematic and collaborative way with the public sector, social marketing groups and product distributors. We draw on lessons learned from the rich experience of earlier efforts to promote a variety of public health interventions in pharmacies and drug shops. To integrate this setting that provides convenience, confidentiality, access to user-controlled contraceptive methods (i.e., pills, condoms and potentially Sayana Press®) and a gateway to clinic-based FP services, we propose three promising practices that should be encouraged in future interventions to increase access to quality FP services.

Institutional Author(s): FHI 360
Individual Author(s): Dawn S. Chin-Quee, John Stanback, Tracy Orr
Publication date: August, 2018

Journal Article Link to Journal Article

Selected practice recommendations for contraceptive use (third edition)

The publication is one of WHO’s evidence-based guidance documents to support and strengthen national contraceptive/family planning programmes. The new and updated practice recommendations contained in this guideline contribute to improving the quality of care in family planning by presenting evidence-based guidance on the safe provision of contraceptive methods for both women and men. The guidelines cover method initiation/continuation, incorrect use, problems during use and programmatic issues for family planning methods.

Institutional Author(s): World Health Organization (WHO)
Publication date: December, 2016

Progestin-only contraception: Injectables and implants

Progestin-only contraceptive injectables and implants are highly effective, longer-acting contraceptive methods that can be used by most women in most circumstances. Globally, 6% of women using modern contraception use injectables and 1% use implants. Injectables are the predominant contraceptive method used in sub-Saharan Africa, and account for 43% of modern contraceptive methods used. A lower-dose, subcutaneous formulation of the most widely used injectable, depot-medroxyprogesterone acetate, has been developed. Implants have the highest effectiveness of any contraceptive method. Commodity cost, which historically limited implant availability in low-resource countries, was markedly lowered between 2012 and 2013. Changes in menstrual bleeding patterns are extremely common with both methods, and a main cause of discontinuation. Advice from normative bodies differs on progestin-only contraceptive use by breastfeeding women 0–6 weeks postpartum. Whether these methods are associated with HIV acquisition is a controversial issue, with important implications for sub-Saharan Africa, which has a disproportionate burden of both human immunodeficiency virus (HIV) and maternal mortality.

Institutional Author(s): University of North Carolina Gillings School of Public Health, USAID
Individual Author(s): Roy Jacobstein, Chelsea B. Polis
Publication date: August, 2014

Journal Article Link to Journal Article